S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Want to Increase Your Conversion Rates? This Is the Biggest Threat to Your Success.
Sell every Stock except ONE (Ad)
Russia accused of 'kidnapping' head of Ukraine nuclear plant
EU chief: New Greece-Bulgaria gas pipeline 'means freedom'
Sell every Stock except ONE (Ad)
Danish Energy Agency says Nord Stream 2 gas pipeline under Baltic Sea appears to have stopped leaking gas
UK train strikes and energy hikes add to a week of turmoil
Sell every Stock except ONE (Ad)
Russia blindfolds, detains Ukraine nuclear plant chief
NIH to fund unproven ALS drugs under patient-backed law
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Want to Increase Your Conversion Rates? This Is the Biggest Threat to Your Success.
Sell every Stock except ONE (Ad)
Russia accused of 'kidnapping' head of Ukraine nuclear plant
EU chief: New Greece-Bulgaria gas pipeline 'means freedom'
Sell every Stock except ONE (Ad)
Danish Energy Agency says Nord Stream 2 gas pipeline under Baltic Sea appears to have stopped leaking gas
UK train strikes and energy hikes add to a week of turmoil
Sell every Stock except ONE (Ad)
Russia blindfolds, detains Ukraine nuclear plant chief
NIH to fund unproven ALS drugs under patient-backed law
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Want to Increase Your Conversion Rates? This Is the Biggest Threat to Your Success.
Sell every Stock except ONE (Ad)
Russia accused of 'kidnapping' head of Ukraine nuclear plant
EU chief: New Greece-Bulgaria gas pipeline 'means freedom'
Sell every Stock except ONE (Ad)
Danish Energy Agency says Nord Stream 2 gas pipeline under Baltic Sea appears to have stopped leaking gas
UK train strikes and energy hikes add to a week of turmoil
Sell every Stock except ONE (Ad)
Russia blindfolds, detains Ukraine nuclear plant chief
NIH to fund unproven ALS drugs under patient-backed law
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Want to Increase Your Conversion Rates? This Is the Biggest Threat to Your Success.
Sell every Stock except ONE (Ad)
Russia accused of 'kidnapping' head of Ukraine nuclear plant
EU chief: New Greece-Bulgaria gas pipeline 'means freedom'
Sell every Stock except ONE (Ad)
Danish Energy Agency says Nord Stream 2 gas pipeline under Baltic Sea appears to have stopped leaking gas
UK train strikes and energy hikes add to a week of turmoil
Sell every Stock except ONE (Ad)
Russia blindfolds, detains Ukraine nuclear plant chief
NIH to fund unproven ALS drugs under patient-backed law
NYSE:ABBV

AbbVie - ABBV News Today

$134.21
-8.51 (-5.96%)
(As of 09/30/2022 12:00 AM ET)
Add
Compare
Today's Range
$134.09
$142.33
50-Day Range
$134.21
$151.15
52-Week Range
$106.86
$175.91
Volume
15.36 million shs
Average Volume
5.28 million shs
Market Capitalization
$237.30 billion
P/E Ratio
19.01
Dividend Yield
3.95%
Price Target
$159.35
Get AbbVie News Delivered to You Automatically

Sign up to receive the latest news and ratings for ABBV and its competitors with MarketBeat's FREE daily newsletter.



ABBV Media Mentions By Week

ABBV Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ABBV
News Sentiment

0.26

0.83

Average
Medical
News Sentiment

ABBV News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ABBV Articles
This Week

19

18

ABBV Articles
Average Week

SourceHeadline
marketbeat.com logoShould AbbVie Inc. Have a Place in Your Dividend Portfolio? 
marketbeat.com - August 26 at 1:05 AM
marketbeat.com logoAre Medtronic And Intuitive Surgical Poised For Big Growth? (ABBV)
marketbeat.com - August 9 at 10:27 AM
marketbeat.com logoTwo Appealing Biotech Stocks for Two Distinct investors (ABBV)
marketbeat.com - August 8 at 11:11 AM
marketbeat.com logo3 Pharma Stocks' Post-Earnings Price Moves
marketbeat.com - August 4 at 6:05 AM
finance.yahoo.com logoHow Far Will AbbVie's Humira Revenue Fall in 2023?
finance.yahoo.com - October 1 at 7:56 PM
fool.com logoHere's Why This Dividend King Is a Buy - The Motley Fool
fool.com - October 1 at 9:55 AM
finance.yahoo.com logoHere's Why This Dividend King Is a Buy
finance.yahoo.com - October 1 at 9:55 AM
benzinga.com logo7 Analysts Have This to Say About AbbVie - AbbVie (NYSE:ABBV) - Benzinga
benzinga.com - September 30 at 6:52 PM
seekingalpha.com logoABBV stock pares losses as SVB Leerink retracts guidance claims (NYSE:ABBV) - Seeking Alpha
seekingalpha.com - September 30 at 6:52 PM
cnbc.com logoWe're upgrading our rating on AbbVie amid a false report on the biopharma's guidance - CNBC
cnbc.com - September 30 at 6:52 PM
stocknews.com logo3 Safe Stocks You'll Want to Have Exposure to in 2022
stocknews.com - September 30 at 4:17 PM
benzinga.com logoAnalyzing AbbVie's Short Interest - AbbVie (NYSE:ABBV) - Benzinga
benzinga.com - September 30 at 1:51 PM
seekingalpha.com logoAbbVie pares losses as SVB Leerink retracts guidance claims
seekingalpha.com - September 30 at 1:26 PM
fool.com logoWhere Will AbbVie Be in 3 Years? - The Motley Fool
fool.com - September 30 at 8:15 AM
finance.yahoo.com logoWhere Will AbbVie Be in 3 Years?
finance.yahoo.com - September 30 at 8:15 AM
finance.yahoo.com logoAbbVie Highlights Robust Gastroenterology Portfolio with New Data in Crohn's Disease and Ulcerative Colitis at the UEG Week 2022
finance.yahoo.com - September 29 at 7:14 AM
finance.yahoo.com logoAbbVie Inc. (NYSE:ABBV) is a favorite amongst institutional investors who own 70%
finance.yahoo.com - September 28 at 9:58 AM
fool.com logo2 High-Yielding Dividend Stocks That Could Raise Their Payouts in October - The Motley Fool
fool.com - September 28 at 4:57 AM
finance.yahoo.com logoXEN® 63 Gel Implant available now for patients with primary open angle glaucoma where previous medical treatments have failed
finance.yahoo.com - September 27 at 8:40 AM
benzinga.com logoCheck Out What Whales Are Doing With ABBV - AbbVie (NYSE:ABBV) - Benzinga
benzinga.com - September 26 at 5:39 PM
stocknews.com logo3 Stocks to Get Bullish on Right Now
stocknews.com - September 26 at 3:57 PM
finance.yahoo.com logoAbbVie Stock Is One To Watch As It Sees RS Rating Jump To 91
finance.yahoo.com - September 26 at 12:39 PM
finance.yahoo.com logoAbbVie Inc.'s (NYSE:ABBV) Business Is Trailing The Market But Its Shares Aren't - Yahoo Finance
finance.yahoo.com - September 24 at 6:18 PM
fool.com logoIs AbbVie a Buy? - The Motley Fool
fool.com - September 24 at 8:17 AM
finance.yahoo.com logoAbbVie Inc.'s (NYSE:ABBV) Business Is Trailing The Market But Its Shares Aren't
finance.yahoo.com - September 24 at 8:17 AM
fool.com logoGot $1,000? 2 Stocks That Could Be Bargain Buys For 2022 and Beyond - The Motley Fool
fool.com - September 23 at 12:11 PM
nasdaq.com logoWhat Could This Drug News Mean for AbbVie? - Nasdaq
nasdaq.com - September 23 at 12:11 PM
finance.yahoo.com logoGot $1,000? 2 Stocks That Could Be Bargain Buys For 2022 and Beyond
finance.yahoo.com - September 23 at 12:11 PM
fool.com logoWhat Could This Drug News Mean for AbbVie? - The Motley Fool
fool.com - September 23 at 7:10 AM
fool.com logoUse These 3 Simple Tricks to Maximize Your Returns From AbbVie Stock - The Motley Fool
fool.com - September 23 at 7:10 AM
finance.yahoo.com logoWhat Could This Drug News Mean for AbbVie?
finance.yahoo.com - September 23 at 7:10 AM
finance.yahoo.com logoUse These 3 Simple Tricks to Maximize Your Returns From AbbVie Stock
finance.yahoo.com - September 23 at 7:10 AM
stocknews.com logo4 Stocks to Buy With Market-Beating Potential
stocknews.com - September 22 at 2:16 PM
finance.yahoo.com logoThe Forces of Beauty® Report from The DREAM Initiative® Reveals Demand for New Standards of Beauty and Imagery
finance.yahoo.com - September 22 at 12:10 PM
businesswire.com logoGlobal Cancer Stem Cell Market to 2030 - Featuring Thermo Fisher Scientific, AbbVie and Lonza Among Others - ResearchAndMarkets.com - Business Wire
businesswire.com - September 21 at 2:13 PM
nasdaq.com logoThe Zacks Analyst Blog Highlights Apple, Amazon, AbbVie, Philip Morris International and BlackRock - Nasdaq
nasdaq.com - September 21 at 9:12 AM
stocknews.com logo3 Stocks Bullish Traders Tend to Fall in Love With
stocknews.com - September 20 at 1:30 PM
seekingalpha.com logoAbbVie Stock: Small Hurdle (NYSE:ABBV) - Seeking Alpha
seekingalpha.com - September 20 at 4:36 AM
nasdaq.com logoThe Zacks Analyst Blog Highlights AbbVie, Novartis, Merck and AstraZeneca - Nasdaq
nasdaq.com - September 19 at 11:35 PM
seekingalpha.com logoAbbVie: Small Hurdle
seekingalpha.com - September 19 at 11:11 PM
businesswire.com logoOutlook on the Analgesics Global Market to 2028 - Featuring AbbVie, Abbott Laboratories, Bayer and Endo International Among Others - ResearchAndMarkets.com - Business Wire
businesswire.com - September 19 at 6:35 PM
finance.yahoo.com logoTop Analyst Reports for Apple, Amazon.com & AbbVie
finance.yahoo.com - September 19 at 6:35 PM
nasdaq.com logoAbbVie Receives CHMP Positive Opinion For Skyrizi For Moderate To Severe Crohn's Disease
nasdaq.com - September 19 at 1:19 PM
msn.com logoCalif. Pharmaceutical Companies AbbVie And Bristol Myers Lay Off 360—Here Are The Major U.S. Layoffs This Summer
msn.com - September 19 at 1:19 PM
msn.com logoEuropean Authority Backs AbbVie's Crohn's Disease Candidate
msn.com - September 19 at 1:19 PM
finance.yahoo.com logoAbbVie Inc.: Diving Into the Drug Pricing Hit From the Inflation Reduction Act, We’ve Reduced Our FVEs by 2%
finance.yahoo.com - September 19 at 1:19 PM
seekingalpha.com logoAbbVie: Valuation Attractive Due To Humira Headwinds
seekingalpha.com - September 19 at 1:19 PM
seekingalpha.com logoAbbVie Vs. Pfizer: Which Is A Better High-Yield Pick (NYSE:ABBV) (NYSE:PFE) - Seeking Alpha
seekingalpha.com - September 19 at 8:19 AM
reuters.com logoBristol Myers, AbbVie plan to cut up to 360 California jobs - Reuters
reuters.com - September 18 at 1:17 AM
stocknews.com logo3 Safe Investments for Seniors to Consider Right Now
stocknews.com - September 16 at 6:51 PM
seekingalpha.com logoOutlook For AbbVie Continues To Look Favorable (NYSE:ABBV) - Seeking Alpha
seekingalpha.com - September 16 at 8:54 AM
seekingalpha.com logoOutlook For AbbVie Continues To Look Favorable
seekingalpha.com - September 15 at 6:49 PM
stocknews.com logoThis 1 Stock Pays You Just for Owning It
stocknews.com - September 15 at 10:42 AM
finance.yahoo.com logoAbbVie to Present Data from Growing Neuroscience and Movement Disorders Portfolio at 2022 MDS International Congress
finance.yahoo.com - September 15 at 5:15 AM
Get AbbVie News Delivered to You Automatically

Sign up to receive the latest news and ratings for ABBV and its competitors with MarketBeat's FREE daily newsletter.

This page (NYSE:ABBV) was last updated on 10/2/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.